{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:38:45Z","timestamp":1778067525831,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7445","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/nature12039","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T16:33:55Z","timestamp":1365525235000},"page":"382-385","source":"Crossref","is-referenced-by-count":117,"title":["Structural basis of kynurenine 3-monooxygenase inhibition"],"prefix":"10.1038","volume":"496","author":[{"given":"Marta","family":"Amaral","sequence":"first","affiliation":[]},{"given":"Colin","family":"Levy","sequence":"additional","affiliation":[]},{"given":"Derren J.","family":"Heyes","sequence":"additional","affiliation":[]},{"given":"Pierre","family":"Lafite","sequence":"additional","affiliation":[]},{"given":"Tiago F.","family":"Outeiro","sequence":"additional","affiliation":[]},{"given":"Flaviano","family":"Giorgini","sequence":"additional","affiliation":[]},{"given":"David","family":"Leys","sequence":"additional","affiliation":[]},{"given":"Nigel S.","family":"Scrutton","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"BFnature12039_CR1","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1074\/jbc.M708192200","volume":"283","author":"F Giorgini","year":"2008","unstructured":"Giorgini, F. et al. Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment. J. Biol. Chem. 283, 7390\u20137400 (2008)","journal-title":"J. Biol. Chem."},{"key":"BFnature12039_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ng1542","volume":"37","author":"F Giorgini","year":"2005","unstructured":"Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C. & Muchowski, P. J. A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nature Genet. 37, 526\u2013531 (2005)","journal-title":"Nature Genet."},{"key":"BFnature12039_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","volume":"145","author":"D Zwilling","year":"2011","unstructured":"Zwilling, D. et al. Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 145, 863\u2013874 (2011)","journal-title":"Cell"},{"key":"BFnature12039_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","volume":"21","author":"S Campesan","year":"2011","unstructured":"Campesan, S. et al. The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington\u2019s disease. Curr. Biol. 21, 961\u2013966 (2011)","journal-title":"Curr. Biol."},{"key":"BFnature12039_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4161\/fly.19999","volume":"6","author":"EW Green","year":"2012","unstructured":"Green, E. W. et al. Drosophila eye color mutants as therapeutic tools for Huntington disease. Fly 6, 117\u2013120 (2012)","journal-title":"Fly"},{"key":"BFnature12039_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz, R., Bruno, J. P., Muchowski, P. J. & Wu, H.-Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nature Rev. Neurosci. 13, 465\u2013477 (2012)","journal-title":"Nature Rev. Neurosci."},{"key":"BFnature12039_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4161\/onci.19071","volume":"1","author":"M Platten","year":"2012","unstructured":"Platten, M., Litzenburger, U. & Wick, W. The aryl hydrocarbon receptor in tumor immunity. Oncoimmunology 1, 396\u2013397 (2012)","journal-title":"Oncoimmunology"},{"key":"BFnature12039_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2174\/156800909790192374","volume":"9","author":"X Liu","year":"2009","unstructured":"Liu, X., Newton, R. C., Friedman, S. M. & Scherle, P. A. Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy. Curr. Cancer Drug Targets 9, 938\u2013952 (2009)","journal-title":"Curr. Cancer Drug Targets"},{"key":"BFnature12039_CR9","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.2174\/092986712803833353","volume":"19","author":"P Filippini","year":"2012","unstructured":"Filippini, P. et al. Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases. Curr. Med. Chem. 19, 5381\u20135393 (2012)","journal-title":"Curr. Med. Chem."},{"key":"BFnature12039_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","volume":"72","author":"TW Stone","year":"1981","unstructured":"Stone, T. W. & Perkins, M. N. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol. 72, 411\u2013412 (1981)","journal-title":"Eur. J. Pharmacol."},{"key":"BFnature12039_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.6849138","volume":"219","author":"R Schwarcz","year":"1983","unstructured":"Schwarcz, R., Whetsell, W. O., Jr & Mangano, R. M. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219, 316\u2013318 (1983)","journal-title":"Science"},{"key":"BFnature12039_CR12","doi-asserted-by":"publisher","first-page":"12553","DOI":"10.1073\/pnas.93.22.12553","volume":"93","author":"S Okuda","year":"1996","unstructured":"Okuda, S., Nishiyama, N., Saito, H. & Katsuki, H. Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc. Natl Acad. Sci. USA 93, 12553\u201312558 (1996)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature12039_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuropharm.2012.03.009","volume":"66","author":"CS Copeland","year":"2013","unstructured":"Copeland, C. S., Neale, S. A. & Salt, T. E. Actions of xanthurenic acid, a putative endogenous group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus. Neuropharmacology 66, 133\u2013142 (2013)","journal-title":"Neuropharmacology"},{"key":"BFnature12039_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1124\/mol.111.074765","volume":"81","author":"F Fazio","year":"2012","unstructured":"Fazio, F. et al. Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors. Mol. Pharmacol. 81, 643\u2013656 (2012)","journal-title":"Mol. Pharmacol."},{"key":"BFnature12039_CR15","doi-asserted-by":"publisher","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","volume":"27","author":"GJ Guillemin","year":"2007","unstructured":"Guillemin, G. J. et al. Characterization of the kynurenine pathway in human neurons. J. Neurosci. 27, 12884\u201312892 (2007)","journal-title":"J. Neurosci."},{"key":"BFnature12039_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","volume":"527","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin, G. J., Smith, D. G., Smythe, G. A., Armati, P. J. & Brew, B. J. Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv. Exp. Med. Biol. 527, 105\u2013112 (2003)","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnature12039_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/00004647-199907000-00007","volume":"19","author":"A Cozzi","year":"1999","unstructured":"Cozzi, A., Carpenedo, R. & Moroni, F. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61\u20138048) in models of focal or global brain ischemia. J. Cereb. Blood Flow Metab. 19, 771\u2013777 (1999)","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnature12039_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-4615-0135-0_15","volume":"527","author":"F Moroni","year":"2003","unstructured":"Moroni, F. et al. Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage. Adv. Exp. Med. Biol. 527, 127\u2013136 (2003)","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnature12039_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejphar.2003.08.038","volume":"478","author":"A Richter","year":"2003","unstructured":"Richter, A. & Hamann, M. The kynurenine 3-hydroxylase inhibitor Ro 61\u20138048 improves dystonia in a genetic model of paroxysmal dyskinesia. Eur. J. Pharmacol. 478, 47\u201352 (2003)","journal-title":"Eur. J. Pharmacol."},{"key":"BFnature12039_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/mds.20596","volume":"20","author":"P Samadi","year":"2005","unstructured":"Samadi, P. et al. Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys. Mov. Disord. 20, 792\u2013802 (2005)","journal-title":"Mov. Disord."},{"key":"BFnature12039_CR21","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1128\/IAI.73.8.5249-5251.2005","volume":"73","author":"CJ Clark","year":"2005","unstructured":"Clark, C. J. et al. Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition. Infect. Immun. 73, 5249\u20135251 (2005)","journal-title":"Infect. Immun."},{"key":"BFnature12039_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2011.05.031","volume":"145","author":"PH Reinhart","year":"2011","unstructured":"Reinhart, P. H. & Kelly, J. W. Treating the periphery to ameliorate neurodegenerative diseases. Cell 145, 813\u2013814 (2011)","journal-title":"Cell"},{"key":"BFnature12039_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.expneurol.2005.07.004","volume":"197","author":"MT Sapko","year":"2006","unstructured":"Sapko, M. T. et al. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntingtons\u2019s disease. Exp. Neurol. 197, 31\u201340 (2006)","journal-title":"Exp. Neurol."},{"key":"BFnature12039_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/jnr.21183","volume":"85","author":"G Ceresoli-Borroni","year":"2007","unstructured":"Ceresoli-Borroni, G., Guidetti, P., Amori, L., Pellicciari, R. & Schwarcz, R. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications. J. Neurosci. Res. 85, 845\u2013854 (2007)","journal-title":"J. Neurosci. Res."},{"key":"BFnature12039_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/oxfordjournals.jbchem.a021930","volume":"123","author":"T Uemura","year":"1998","unstructured":"Uemura, T. & Hirai, K. l-kynurenine 3-monooxygenase from mitochondrial outer membrane of pig liver: purification, some properties, and monoclonal antibodies directed to the enzyme. J. Biochem. 123, 253\u2013262 (1998)","journal-title":"J. Biochem."},{"key":"BFnature12039_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.abb.2009.11.028","volume":"493","author":"BA Palfey","year":"2010","unstructured":"Palfey, B. A. & McDonald, C. A. Control of catalysis in flavin-dependent monooxygenases. Arch. Biochem. Biophys. 493, 26\u201336 (2010)","journal-title":"Arch. Biochem. Biophys."},{"key":"BFnature12039_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jbiotec.2006.03.044","volume":"124","author":"WJH van Berkel","year":"2006","unstructured":"van Berkel, W. J. H., Kamerbeek, N. M. & Fraaije, M. W. Flavoprotein monooxygenases, a diverse class of oxidative biocatalysts. J. Biotechnol. 124, 670\u2013689 (2006)","journal-title":"J. Biotechnol."},{"key":"BFnature12039_CR28","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1021\/bi900149f","volume":"48","author":"KM McCulloch","year":"2009","unstructured":"McCulloch, K. M., Mukherjee, T., Begley, T. P. & Ealick, S. E. Structure of the PLP degradative enzyme 2-methyl-3- hydroxypyridine-5-carboxylic acid oxygenase from Mesorhizobium loti MAFF303099 and its mechanistic implications. Biochemistry 48, 4139\u20134149 (2009)","journal-title":"Biochemistry"},{"key":"BFnature12039_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/bi002139s","volume":"40","author":"M Ortiz-Maldonado","year":"2001","unstructured":"Ortiz-Maldonado, M., Ballou, D. P. & Massey, V. A rate-limiting conformational change of the flavin in p-hydroxybenzoate hydroxylase is necessary for ligand exchange and catalysis: studies with 8-mercapto- and 8-hydroxy-flavins. Biochemistry 40, 1091\u20131101 (2001)","journal-title":"Biochemistry"},{"key":"BFnature12039_CR30","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y. & Smith, Q. R. Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56, 2007\u20132017 (1991)","journal-title":"J. Neurochem."},{"key":"BFnature12039_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D 66, 125\u2013132 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature12039_CR32","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1107\/S0907444904009990","volume":"60","author":"AJ McCoy","year":"2004","unstructured":"McCoy, A. J., Storoni, L. C. & Read, R. J. Simple algorithm for a maximum-likelihood SAD function. Acta Crystallogr. D 60, 1220\u20131228 (2004)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature12039_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1107\/S090744490705024X","volume":"64","author":"TC Terwilliger","year":"2008","unstructured":"Terwilliger, T. C. et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr. D 64, 61\u201369 (2008)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature12039_CR34","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature12039_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature12039_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007)","journal-title":"J. Appl. Crystallogr."},{"key":"BFnature12039_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12\u201321 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature12039_CR38","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jcc.20289","volume":"26","author":"JC Phillips","year":"2005","unstructured":"Phillips, J. C. et al. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781\u20131802 (2005)","journal-title":"J. Comput. Chem."},{"key":"BFnature12039_CR39","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1021\/ja00124a002","volume":"117","author":"WD Cornell","year":"1995","unstructured":"Cornell, W. D. et al. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117, 5179\u20135197 (1995)","journal-title":"J. Am. Chem. Soc."},{"key":"BFnature12039_CR40","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/jcc.10128","volume":"23","author":"A Jakalian","year":"2002","unstructured":"Jakalian, A., Jack, D. B. & Bayly, C. I. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J. Comput. Chem. 23, 1623\u20131641 (2002)","journal-title":"J. Comput. Chem."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature12039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature12039","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature12039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:10:09Z","timestamp":1684433409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature12039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":40,"journal-issue":{"issue":"7445","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFnature12039"],"URL":"https:\/\/doi.org\/10.1038\/nature12039","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}